A single-blind study is an experiment where participants don’t know whether they’re receiving the real treatment or a placebo, but the researchers running the study do know. This design is one of the most common ways psychologists control for bias when testing whether a treatment, intervention, or experimental manipulation actually works. The “blind” refers to the information being hidden: participants can’t see which group they’ve been placed in, which prevents their expectations from skewing the results.
How Single Blinding Works
In a typical single-blind psychology experiment, participants are randomly assigned to either an experimental group or a control group. The experimental group receives the actual treatment or intervention being tested, while the control group receives a placebo or sham version. The key feature is that participants aren’t told which group they’re in. They might all receive identical-looking capsules, go through similar-seeming activities, or interact with the same equipment, so no one can tell from the experience alone whether they got the real thing.
The researchers, however, know exactly who is in which group. They need this information to administer the correct treatment, track results, and manage the logistics of the experiment. This is what separates single-blind from double-blind designs, where even the researchers interacting with participants are kept in the dark.
Why Participant Blinding Matters
The main threat that single blinding addresses is the placebo effect. When people believe they’re receiving an effective treatment, they often improve regardless of whether the treatment itself does anything. In psychology, this is especially powerful because many outcomes, like mood, anxiety, perceived energy, or pain tolerance, are subjective. If a participant knows they got the real intervention, their belief alone can shift their self-reported experience.
There’s a related problem called demand characteristics. When participants figure out (or think they’ve figured out) what the study is testing, they tend to adjust their behavior, sometimes unconsciously. They might try to confirm what they think the researcher expects, or they might do the opposite. Either way, the data no longer reflects the actual effect of the treatment. Blinding participants to their group assignment is one of the primary tools for preventing these unwanted influences on responses.
Keeping the blind intact isn’t always straightforward. Research on psychedelic microdosing trials found that when participants were asked to guess whether they received a real dose or a placebo, many guessed correctly at rates above chance. When that happens, blinding has effectively failed, and expectancy effects can creep back in. One study introduced a statistical tool to estimate what results would look like in a perfectly blinded trial versus an imperfectly blinded one, and found that some reported differences between drug and placebo groups were likely false positives driven by participants’ expectations rather than the substance itself.
What Single Blinding Doesn’t Prevent
The major limitation of a single-blind study is that the researcher still knows who’s getting what. This opens the door to experimenter expectancy effects, a well-documented phenomenon where a researcher’s knowledge of a participant’s group subtly influences how they interact with that person. The bias isn’t necessarily intentional. A researcher who knows a participant received caffeine might unconsciously rate that person’s energy level higher, or use a slightly more enthusiastic tone during instructions, or interpret ambiguous behavior in a way that confirms their hypothesis.
These effects can be surprisingly large. Research has shown that when experimenters are not blinded to experimental condition, biases are common across many study situations, even when experimenter-participant contact is limited. A systematic review of published studies found that a majority did not adequately control for experimenter bias, and that multiple independent replication attempts with added controls failed to reproduce the original effects. In other words, what looked like a real finding was better explained by the researcher’s expectations leaking into the data.
This is why double-blind designs exist. When a study measures outcomes that require researcher judgment, like rating a participant’s behavior, interpreting facial expressions, or scoring open-ended responses, the risk of experimenter bias is high enough that blinding both parties becomes important.
When Single Blinding Is the Right Choice
Single-blind designs are appropriate when the researcher’s knowledge of group assignment is unlikely to contaminate the results. If participants complete a survey on a computer with no researcher present, or if the outcome is an objective measurement like reaction time or a physiological reading, the researcher knowing who’s in which group matters much less. As Penn State’s statistics curriculum notes, a double-blind design may not be necessary when researchers have only minimal contact with participants.
Single blinding also becomes the practical choice when double blinding simply isn’t possible. In many psychology experiments, the researcher has to deliver the intervention personally: leading a therapy session, guiding a mindfulness exercise, or facilitating a group activity. You can’t hide from a therapist whether they’re delivering cognitive behavioral therapy or a control condition. In these cases, single blinding the participants is the best available option.
Early clinical research recognized this logic. A 1954 crossover study on treatments for Parkinson’s disease used identical capsules so patients couldn’t distinguish the real medication from a placebo. The researchers noted that the placebo condition helped them separate genuine pharmacological effects from the “psychological urge to improve” that came simply from receiving tablets and extra attention. That same principle drives psychology experiments today.
Single Blind vs. Double Blind
The distinction is straightforward. In a single-blind study, participants don’t know their group assignment but researchers do. In a double-blind study, neither participants nor the researchers who interact with them know. Double blinding adds a layer of protection against experimenter bias, making it the stronger design when feasible.
Consider a study testing whether caffeine improves focus. In a single-blind version, all participants drink identical-tasting beverages, some with caffeine and some without, and don’t know which they received. The researcher, who does know, asks them to complete attention tasks and then rates their performance. The risk here is that the researcher might unconsciously score the caffeine group more favorably. In a double-blind version, a separate team member codes the beverages so neither the participant nor the researcher administering the tasks knows which beverage was which. The rating stays unbiased.
Double-blind designs aren’t always better in practice. They’re more expensive, more logistically complex, and sometimes impossible. When the outcome measure is objective and researcher contact is minimal, the added protection of double blinding may not justify the cost.
Ethical Considerations
Blinding requires withholding information from participants, which creates a tension with informed consent. The American Psychological Association’s ethics code requires researchers to obtain informed consent using language that is reasonably understandable to participants. In practice, this means participants in a single-blind study are told that they might receive a placebo or an active treatment and that they won’t know which one until the study is over. They consent to not knowing. What they’re not told is their specific group assignment.
Updated reporting guidelines from CONSORT 2025 now require researchers to clearly state who was blinded in any trial, how blinding was achieved, how similar the real and placebo treatments were made to look, and whether blinding was compromised at any point. This matters because terms like “single-blind” and “double-blind” have historically been used loosely, and without specifics, readers can’t judge whether the blinding actually worked. A study that calls itself single-blind but uses an obvious placebo hasn’t really blinded anyone.